Unravel Health is a developer of home hormone monitoring technology.
Unravel Health has raised €3.0M across 1 funding round from 6 investors, most recently a round in Oct 2026. Based in London, UK; active in Healthtech. Data as of 20 Oct 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-19 | Other |
| €3.0M |
| Embryo Ventures,HERmesa,Leo Capital,The Conduit EIS Impact Fund,Wrightwood,Zinc VC |
| View deal → |
